SCHEMBL660292

SCHEMBL660292

O=C(CN1C=CCC(C(=O)NCCO)=C1)Nc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
NPC1 O15118 3/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RAB9A P51151 2/20 0.39
HTT P42858 1/20 0.39
TP53 P04637 1/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659235 0.88 HTT (0.45) ALDH1A1LMNAHTTMEN1KMT2A
SCHEMBL287728 0.84 NPSR1 (0.46) ALDH1A1NPC1LMNAKDM4ESMN1; SMN2
SCHEMBL287827 0.83 ALDH1A1 (0.41) ALDH1A1NPC1LMNAKDM4ESMN1; SMN2
SCHEMBL658611 0.82 CA12 (0.32) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL660868 0.79 LMNA (0.33) ALDH1A1LMNAKDM4EHTTMEN1
SCHEMBL287496 0.78 KAT6A (0.44) ALDH1A1HTTMEN1KMT2ACHRNB2
SCHEMBL286819 0.77 MAPT (0.43) ALDH1A1NPC1LMNAKDM4ESMN1; SMN2
SCHEMBL27573479 0.74 ALDH1A1 (0.43) ALDH1A1NPC1LMNAKDM4ESMN1; SMN2
SCHEMBL659968 0.74 TSHR (0.37) ALDH1A1SMN1; SMN2RAB9AHTTTP53
SCHEMBL659963 0.74 KLK7 (0.48) ALDH1A1NPC1LMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT ALDH1A1 676/4885NPC1 1176/4885LMNA 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.